Covered recipient · General Payments record
ARCHIL ABASHIDZE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$4,043.30
- Reported across 223 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $557.54 | 34 |
| Education | $8.61 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lundbeck LLC | $172.83 | 9 |
| ABBVIE INC. | $171.73 | 13 |
| Alkermes, Inc. | $139.95 | 10 |
| ITI, Inc. | $26.52 | 1 |
| Otsuka America Pharmaceutical, Inc. | $21.29 | 1 |
| Janssen Pharmaceuticals, Inc | $17.23 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.91 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161524 | CMS |
| ABBVIE INC. | $27.11 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161526 | CMS |
| ABBVIE INC. | $13.81 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161528 | CMS |
| ABBVIE INC. | $4.87 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161530 | CMS |
| ABBVIE INC. | $4.99 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161532 | CMS |
| ABBVIE INC. | $17.60 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161534 | CMS |
| ABBVIE INC. | $24.11 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161536 | CMS |
| ABBVIE INC. | $3.33 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161538 | CMS |
| ABBVIE INC. | $14.39 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161540 | CMS |
| ABBVIE INC. | $26.06 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161542 | CMS |
| ABBVIE INC. | $3.33 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161544 | CMS |
| ABBVIE INC. | $22.25 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161546 | CMS |
| ABBVIE INC. | $3.97 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161548 | CMS |
| Alkermes, Inc. | $18.89 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120452542 | CMS |
| Alkermes, Inc. | $14.42 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120452544 | CMS |
| Alkermes, Inc. | $11.33 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120452546 | CMS |
| Alkermes, Inc. | $18.45 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120452548 | CMS |
| Alkermes, Inc. | $19.11 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120452550 | CMS |
| Alkermes, Inc. | $22.47 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120452552 | CMS |
| Alkermes, Inc. | $12.87 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120452554 | CMS |
| Alkermes, Inc. | $1.68 | 12/18/2024 | Education | Undisputed | 01/23/2026 | 1120452540 | CMS |
| Alkermes, Inc. | $6.93 | 12/18/2024 | Education | Undisputed | 01/23/2026 | 1120452556 | CMS |
| Alkermes, Inc. | $13.80 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120452558 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.60 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101812667 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26.52 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143178517 | CMS |
| Janssen Pharmaceuticals, Inc | $17.23 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078044936 | CMS |
| Lundbeck LLC | $17.41 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145888210 | CMS |
| Lundbeck LLC | $23.90 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145888212 | CMS |
| Lundbeck LLC | $16.63 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145888214 | CMS |
| Lundbeck LLC | $16.22 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145888216 | CMS |
| Lundbeck LLC | $24.33 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145888218 | CMS |
| Lundbeck LLC | $18.73 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145888220 | CMS |
| Lundbeck LLC | $13.42 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145888222 | CMS |
| Lundbeck LLC | $21.81 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145888224 | CMS |
| Lundbeck LLC | $20.38 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145888226 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.29 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118847026 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.